Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 5 of 5343 results
Sort by: relevance publication year

Implication of99mTc-sum IL-2 SPECT/CT in immunotherapy by imaging of tumor-infiltrating T cells

JOURNAL ARTICLE published March 2023 in Journal for ImmunoTherapy of Cancer

Research funded by Emergency Key Program of Guangzhou (EKPG21-16) | National Natural Science Foundation of China (81630045,81927802,81971676,92159201)

Authors: Yu Gao | Qi Luo | Zhichen Sun | Hannan Gao | Yue Yu | Yining Sun | Xiaotu Ma | Chuanhui Han | Jiyun Shi | Fan Wang

Longitudinal evaluation of the biodistribution and cellular internalization of the bispecific CD3xTRP1 antibody in syngeneic mouse tumor models

JOURNAL ARTICLE published October 2023 in Journal for ImmunoTherapy of Cancer

Research funded by Genmab (N/A) | Nederlandse Organisatie voor Wetenschappelijk Onderzoek (09150172010054)

Authors: Gerwin Gerhard Wemke Sandker | Jim Middelburg | Evienne Wilbrink | Janneke Molkenboer-Kuenen | Erik Aarntzen | Thorbald van Hall | Sandra Heskamp

Treatment of mycophenolate-resistant immune-related organizing pneumonia with infliximab

JOURNAL ARTICLE published December 2018 in Journal for ImmunoTherapy of Cancer

Authors: Guacimara Ortega Sanchez | Kathleen Jahn | Spasenija Savic | Alfred Zippelius | Heinz Läubli

Safety and efficacy of autologous and allogeneic humanized CD19-targeted CAR-T cell therapy for patients with relapsed/refractory B-ALL

JOURNAL ARTICLE published February 2023 in Journal for ImmunoTherapy of Cancer

Research funded by Key projects of the National Natural Science Foundation of China (81730008,82130003) | key R & D Program of Zhejiang Province (2018C03016-2,2019C03016) | General Project of the National Natural Science Foundation of China (81870153)

Authors: Fengmei Song | Yongxian Hu | Yanlei Zhang | Mingming Zhang | Tingting Yang | Wenjun Wu | Simao Huang | Huijun Xu | Alex H Chang | He Huang | Guoqing Wei

Carbon nanomaterials as contrast agents for breast cancer diagnosis and therapy

JOURNAL ARTICLE published 2015 in Journal for ImmunoTherapy of Cancer

Authors: Sara Dolci | Valentina Domenici | Gianpaolo Vidili | Elisabetta Avitabile | Marco Orecchioni | Alberto Bianco | Lucia Delogu

591 Survival rates in Stage IV melanoma patients treated with radiation and immunotherapy differ depending on age and radiation treatment site

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Catherine Colonna | Nasreen Vohra | Aiden Burke | Matthew Peach | Andrew Ju

907 Modulation of tumor immunogenicity by DNA methylation of immune synapse genes in cancers

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Imene Hamaidi | Anders Berglund | Matthew Mills | Ryan Putney | James Mule | Sungjune Kim

891 S-531011, a novel anti-human CCR8 antibody: antibody screening and evaluation of biological profiles

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Mai Yoshikawa | Yoji Nagira | Morio Nagira | Tetsuya Yoshida | Shinpei Yoshida | Tetsuyoshi Soh | Hisashi Wada | Naganari Ohkura | Tatsuya Takahashi

195 Stimulation of tumor infiltrating B-cells improves ex-vivo TIL expansion for melanoma immunotherapy

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Renata Rossetti | Leticia Tordesillas | Matthew Beatty | Yian Ann Chen | Dongliang Du | Amod Sarnaik | Shari Pilon-Thomas | Daniel Abate-Daga

Correction: Overexpression of CD200 is a stem cell-specific mechanism of immune evasion in AML

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

178 Expansion of Tumor-Infiltrating Lymphocytes and Marrow-Infiltrating Lymphocytes from Pediatric Malignant Solid Tumors

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Jonathan Metts | Jonathan Hensel | Alejandro Alfaro | Brook Olmo | Shari Pilon-Thomas | John Mullinax | Ivanna Leon

234 Distinct efficacy and immunological responses to αPD-1, αPD-L1 and αPD-L2 immunotherapy in aged versus young hosts

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Yilun Deng | Harshita Gupta | Myrna Garcia | Aravind Kancharla | Ryan Reyes | Alvaro Padron | Tyler Curiel

Antigen-specific T cells conditioned with MDSC display a surprising increased anti-tumor activity after adoptive T cell-based immunotherapy

JOURNAL ARTICLE published 2015 in Journal for ImmunoTherapy of Cancer

Authors: Patrick Raber | Paul Thevenot | Rosa Sierra | Paulo C Rodriguez

241 Immune checkpoint blockade (ICB) in brain metastases (BM) from advanced small cell urothelial cancer (aSCUC)

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Nathaniel Wilson | Omar Alhalabi | Elshad Hasanov | Lianchun Xiao | John Papadopoulos | Matthew Campbell | Amishi Shah | Jianjun Gao | Paul Corn | Ana Aparicio | Jennifer Wang | Bogdan Czerniak | Charles Guo | Christopher Logothetis | Jing Li | Seungtaek Choi | Chad Tang | Nizar Tannir | Arlene Siefker-Radtke

Systems biology analysis of immune signaling in peripheral blood mononuclear cells (PBMC) of melanoma patients receiving ipilimumab; basis for clinical response biomarker identification

JOURNAL ARTICLE published November 2013 in Journal for ImmunoTherapy of Cancer

Authors: Drew Hotson | Ryan Alvarado | Andrew Conroy | Santosh Putta | Ester Simeone | Assunta Esposito | Mariaelena Capone | Gabriele Madonna | Antonio M Grimaldi | David Rosen | Spencer Liang | Alessandra Cesano | Paolo A Ascierto | Rachael Hawtin

Tumor associated MUC1 carried by microvesicles is cross-processed by dendritic cells generating CD8+ T cell response

JOURNAL ARTICLE published November 2013 in Journal for ImmunoTherapy of Cancer

Authors: Ilaria G Zizzari | Federico Battisti | Chiara Napoletano | Hassan Rahimi | Salvatore Caponnetto | Paola Martufi | Stefania Salvati | Morena Antonilli | Francesca Belleudi | Marianna Nuti | Aurelia Rughetti

Evaluation of novel immunocytokines that preferentially target high or intermediate affinity IL-2 receptors

JOURNAL ARTICLE published 2014 in Journal for ImmunoTherapy of Cancer

Authors: Zulmarie Perez Horta | Stephen Gillies | Margaret Boyden | Jaquelyn Hank | Alexander Rahkmilevich | Paul Sondel

174 Combined IL-2, agonistic CD3 and 4–1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Meredith Frank | Parin Shah | Marie Andree Forget | Lorenzo Federico | Peixin Jiang | Roohussaba Khairullah | Ignacio Wistuba | Chi-Wan Chow | Yan Long | Junya Fujimoto | Shiaw-Yih Lin | Anirban Maitra | Marcelo Negrao | Kyle Mitchell | Annika Weissferdt | Ara Vaporciyan | Tina Cascone | Jack Roth | Jianjun Zhang | Boris Sepesi | Don Gibbons | John Heymach | Cara Haymaker | Daniel McGrail | Chantale Bernatchez | Alexandre Reuben

Rapid monitoring of reconstituted Wilms' tumor suppressor gene-specific t lymphocytes after allogeneic stem cell transplantation using quantitative real time Polymerase chain reaction

JOURNAL ARTICLE published February 2014 in Journal for ImmunoTherapy of Cancer

Authors: Ahmad A Ab-Khader | Stefan Krause | Ernst Holler

586 Monitoring the impact of MDSC targeting drugs in combination with nivolumab on activation and proliferation of tumor resident effector immune cells in patient-derived 3D-EXplore platform

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Jared Ehrhart | Brittany Bunch | Kelly Sussman | Kelly Guzman | Soner Altiok